These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8209757)

  • 1. Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3.
    Chung S; Li C; Fung LS; Crow A; Gorczynski R; Cole E; Perlman S; Leibowitz J; Levy G
    Adv Exp Med Biol; 1993; 342():377-84. PubMed ID: 8209757
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
    Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
    J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection.
    Fung LS; Neil G; Leibowitz J; Cole EH; Chung S; Crow A; Levy GA
    J Biol Chem; 1991 Jan; 266(3):1789-95. PubMed ID: 1846363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.
    Li C; Fung LS; Chung S; Crow A; Myers-Mason N; Phillips MJ; Leibowitz JL; Cole E; Ottaway CA; Levy G
    J Exp Med; 1992 Sep; 176(3):689-97. PubMed ID: 1324969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.
    Levy GA; Leibowitz JL; Edgington TS
    J Exp Med; 1981 Oct; 154(4):1150-63. PubMed ID: 6270227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.
    Pope M; Rotstein O; Cole E; Sinclair S; Parr R; Cruz B; Fingerote R; Chung S; Gorczynski R; Fung L
    J Virol; 1995 Sep; 69(9):5252-60. PubMed ID: 7636967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
    Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
    Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early cellular events in the induction of murine hepatitis virus (MHV-3) induced macrophage procoagulant activity (PCA).
    Chung S; Downey G; Rotstein O; Levy G
    Adv Exp Med Biol; 1993; 342():385-8. PubMed ID: 8209758
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro.
    Chung S; Sinclair S; Leibowitz J; Skamene E; Fung LS; Levy G
    J Immunol; 1991 Jan; 146(1):271-8. PubMed ID: 1701794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59.
    Wijburg OL; Heemskerk MH; Boog CJ; Van Rooijen N
    Immunology; 1997 Oct; 92(2):252-8. PubMed ID: 9415034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of resistant A/J mice with methylprednisolone (MP) results in loss of resistance to murine hepatitis strain 3 (MHV-3) and induction of macrophage procoagulant activity (PCA).
    Fingerote RJ; Leibowitz JL; Rao YS; Levy GA
    Adv Exp Med Biol; 1995; 380():89-94. PubMed ID: 8830551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHV-3 induced prothrombinase is encoded by musfiblp.
    Parr RL; Fung L; Reneker J; Myers-Mason N; Leibowitz JL; Levy G
    Adv Exp Med Biol; 1995; 380():151-7. PubMed ID: 8830472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe combined immunodeficiency (SCID) mouse hepatitis experimentally induced with low virulence mouse hepatitis virus.
    Uetsuka K; Nakayama H; Goto N; Fujiwara K
    Adv Exp Med Biol; 1995; 380():105-7. PubMed ID: 8830462
    [No Abstract]   [Full Text] [Related]  

  • 16. Age-related changes in susceptibility of mice to low-virulent mouse hepatitis virus (MHV-2-CC) infection.
    Suzuki H; Kiatipattanasakul W; Kajikawa S; Tsutsui S; Nakayama H; Goto N; Doi K
    Exp Anim; 1997 Jul; 46(3):211-8. PubMed ID: 9250482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.
    Khanolkar A; Fulton RB; Epping LL; Pham NL; Tifrea D; Varga SM; Harty JT
    J Immunol; 2010 Jul; 185(2):1132-41. PubMed ID: 20554960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
    Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
    Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
    Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.